Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moorfields Pharmaceuticals was the commercial pharmaceutical arm of the Moorfields Eye Hospital NHS Foundation Trust, based in London. The company was a specialist manufacturer of ophthalmic products, providing a comprehensive range of licensed medicines and 'specials' to treat various eye conditions. Its expertise included the production of preservative-free eye drops and complex formulations for rare ocular diseases that were not met by mass-market manufacturers. In 2016, the company was acquired by Rayner, a global leader in intraocular lens manufacturing, to form the basis of Rayner's pharmaceutical division. This acquisition allowed Rayner to offer a broader range of ophthalmic solutions alongside its surgical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moorfields Pharmaceuticals.